Brief: BCAL Diagnostics Says Validation Agreement Signed With Sonic USA, For Breastest V2
27/05/2026 23:41
BRIEF-BCAL Diagnostics Says Validation Agreement Signed With Sonic USA, For Breastest V2 May 28 (Reuters) - BCAL Diagnostics Ltd BDX.AX:
VALIDATION AGREEMENT SIGNED WITH SONIC USA, FOR BREASTEST V2
VALIDATION TO BE CONDUCTED IN CLIA-CERTIFIED SONIC LABORATORY IN AUSTIN, TEXAS
SONIC HEALTHCARE USA MAY NEGOTIATE COMMERCIAL LICENCE FOR BREASTESTPLUS VERSION 2 POST-VALIDATION
Further company coverage: BDX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BCAL Diagnostics
See all newsBrief: Bcal Diagnostics Secures A$4.9 Million Under Convertible Note Facility
Australia's BCAL Diagnostics soars on development of new blood test for breast cancer
Brief: BCAL Diagnostics Says Validation Agreement Signed With Sonic USA, For Breastest V2
Australia's BCAL Diagnostics launches early detection cancer platform, shares rise
Brief: BCAL Diagnostics Launches Early Detection Cancer Platform